NCS Multistage (NCSM) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
6 Mar, 2026Executive summary
Achieved strong financial performance in 2025, with revenue up 13% year-over-year to $183.6 million, exceeding guidance and driven by leadership in well construction, completion technologies, and the ResMetrics acquisition.
Q4 2025 revenue reached $50.6 million, up 13% year-over-year, with operating income up 78% and net income of $15.0 million, including a $9.8 million deferred tax valuation allowance benefit.
Maintained a capital-light, asset-light business model, generating robust free cash flow and supporting strategic acquisitions and organic growth.
Integration of ResMetrics enhanced tracer diagnostics capabilities, expanded market reach in the U.S. and Middle East, and contributed to revenue and cost synergies.
Continued investment in technology, operational efficiency, and product innovation, including new solutions such as ATRS AICV, RapidTrace, Lumen8, and SmartProp tracer.
Financial highlights
Full-year 2025 revenue was $183.6 million, up from $162.6 million in 2024; adjusted EBITDA rose 20% to $26.7 million (margin 15%).
Free cash flow after distributions to non-controlling interest totaled $18.9 million, with over 70% conversion from adjusted EBITDA.
Net income for 2025 was $23.7 million, or $8.65 per diluted share, including $11.5 million benefit from deferred tax valuation allowance release.
Ended 2025 with $36.7 million in cash, $7.6 million in debt, and $29.1 million net cash position; total liquidity was $61.1 million.
Adjusted gross margin for 2025 was 41%; Q4 gross margin was 40%, with adjusted Q4 margin at 42%.
Outlook and guidance
2026 revenue guidance: $184–$194 million; adjusted EBITDA: $26–$29 million; free cash flow after distributions: $12–$16 million.
Q1 2026 revenue expected at $49–$53 million; adjusted gross margin 39–41%; adjusted EBITDA $6.5–$8.5 million.
Capital expenditures for 2026 expected at $1.5–$2 million.
Revenue growth anticipated in U.S. and international markets, with Canadian revenue expected to decline due to lower rig count and customer consolidation.
Market environment expected to remain challenging in North America, with international growth weighted to the second half of 2026.
Latest events from NCS Multistage
- Q2 2024 revenue up 17% with improved margins and raised 2024 guidance on strong international growth.NCSM
Q2 20242 Feb 2026 - Q3 2024 revenue up 15% year-over-year, with strong global demand and margin expansion.NCSM
Q3 202417 Jan 2026 - Strong 2024 growth, innovation, and international expansion drive robust margins and free cash flow.NCSM
Emerging Growth Virtual Conference27 Dec 2025 - Record international growth, margin expansion, and strong cash position highlight 2024 results.NCSM
Q4 202425 Dec 2025 - Q1 revenue and profit surged on Canadian and international strength, with margins expanding.NCSM
Q1 202524 Dec 2025 - Up to $200M in common stock registered for sale, supporting growth amid oilfield sector risks.NCSM
Registration Filing16 Dec 2025 - Strong international growth, margin expansion, and strategic acquisitions drive robust free cash flow.NCSM
Sidoti's Year End Virtual Investor Conference12 Dec 2025 - Stockholders will vote on directors, auditor, executive pay, and an expanded equity plan.NCSM
Proxy Filing1 Dec 2025 - Key votes include director elections, auditor ratification, and executive pay approval.NCSM
Proxy Filing1 Dec 2025